Citadel Advisors
BLU

Citadel Advisors’s BELLUS Health Inc. BLU Stock Holding History

Citadel Advisors’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26,000
Closed -$187K – 15622
2023
Q1 		$187K Buy
26,000
+4,300
+20% +$33.4K ﹤0.01% 10296
2022
Q4 		$178K Sell
21,700
-9,700
-31% -$90.4K ﹤0.01% 10337
2022
Q3 		$332K Buy
31,400
+18,200
+138% +$193K ﹤0.01% 9348
2022
Q2 		$122K Sell
13,200
-28,900
-69% -$236K ﹤0.01% 11197
2022
Q1 		$290K Buy
+42,100
New +$271K ﹤0.01% 10672
2021
Q4 		– Sell
-53,800
Closed -$330K – 15151
2021
Q3 		$330K Buy
+53,800
New +$204K ﹤0.01% 10864

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.32B AUM 51.82% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Citadel Advisors's BLU Position: Q2 2023 in Review

Citadel Advisors sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 4,290,398 shares — an estimated $30.9M sold.

Citadel Advisors first reported a position in BLU in Q3 2019 and held it in 15 quarters. The position peaked at $42.2M in Q2 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Citadel Advisors reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 4,290,398 BELLUS Health Inc. shares in Q2 2023, an estimated $30.9M.
  • Citadel Advisors first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 15 quarters.
  • Citadel Advisors's BELLUS Health Inc. position peaked at $42.2M in Q2 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.